Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Chiral Quest Closes $13 Million Series B

publication date: Nov 16, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Chiral Quest Corporation raised $13 million in a Series B financing from China-based venture capitalists, including KPCB China (Kleiner Perkins Caufield & Byers), China Spring Fund, JAIC (Japan Asia Investment Co.), and returning investor Infinity i-China. Chiral Quest offers its chiral expertise to biopharmas, developing manufacturing processes for drug candidates. In December 2007, Chiral Quest was voted the “Most Promising Company” in the Services sector at the ChinaBio® Investor Forum, held in Shanghai. More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners